The new generation tyrosine kinase inhibitor improves the survival of chronic myeloid leukemia patients after allogeneic stem cell transplantation
暂无分享,去创建一个
J. Ishikawa | T. Nagamura-Inoue | T. Ichinohe | Y. Atsuta | Y. Ozawa | T. Fukuda | N. Doki | S. Yano | M. Murata | T. Tachibana | Y. Minami | H. Nakamae | J. Tanaka | N. Uchida | J. Kato | Takahide Ara | Y. Shimazu | T. Kondo | T. Eto | Cellular Therapy